AUS
NZ
UK
CA
USA
IND
_03_12_2025_07_01_24_669414.jpg)
Highlights
- United-Guardian is involved in the production of cosmetic ingredients, pharmaceuticals, and specialty industrial products.
- Recent institutional activity shows an increase in stakes by several major investors.
- The stock has demonstrated a varied price performance, with notable highs and lows over the past year.
United-Guardian, Inc. operates in diverse markets by manufacturing and marketing a variety of products, including cosmetic ingredients, medical lubricants, pharmaceuticals, and specialty industrial products across the United States and internationally. The company has developed a broad range of cosmetic ingredients such as the LUBRAJEL line, known for enhancing sensory characteristics and providing lubrication in personal care products. The diverse lineup includes LUBRAJEL NATURAL for skin moisturizing, LUBRAJEL MARINE for natural product development, and several others aimed at delivering unique textures and properties.
Stock Performance
The stock performance of United-Guardian (NASDAQ:UG) has seen some fluctuations. It opened at $9.83 recently, with its 50-day simple moving average standing at $10.50, whereas the 200-day simple moving average was $11.67. Notably, the stock's 52-week range spans a low of $7.02 to a high of $16.25, aligning with a market capitalization of $45.18 million. It has a price-to-earnings ratio of 12.94 and a beta of 0.73, indicating moderate volatility.
Institutional Investor Activity
The involvement of institutional investors in United-Guardian has seen an uptrend. Geode Capital Management LLC increased its holdings by 8.3% in the third quarter, now owning 28,335 shares valued at approximately $450,000. Additionally, Northern Trust Corp boosted its holdings by 69.5% in the fourth quarter, acquiring 25,527 shares worth $244,000. Renaissance Technologies LLC also increased its stake by 4.3% during the same period. Meanwhile, new stakes were acquired by United Capital Financial Advisors LLC and Heron Bay Capital Management, highlighting the growing interest of institutional investors, who presently manage 23.16% of the company's stock.
United-Guardian continues to be a company of interest for institutional investors, demonstrated by increased activity and new stakes in its stock. The company's broad product offerings and its varied stock performance offer valuable insights for those engaged in monitoring market trends in related sectors.
